UI Hospitals and Clinics

Studies | Researchers

Clinical Research

Showing newest first. Show oldest first. Or order by title

  1. Phase 2 Efficacy and Safety Study of Intravenous GPX-150, an Anthracycline Analog, in Patients with Soft Tissue Sarcoma
    Mohammed Milhem
  2. A Randomized Controlled Phase 3 Study of Oral Pacritinib versus Best Available Therapy in Patients with Thrombocytopenia and Primary Myelofibrosis, Post-Polycythemia Vera Myelofibrosis, or Post-Essent…
    Usha Perepu
  3. Phase 1 / Comparative Randomized Phase II Trial of TRC105 + Bevacizumab vs Bevacizumab in Bevacizumab-Naive Patients with Recurrent Glioblastoma Multiforme
    Mohammed Milhem
  4. A Phase 1, First-in-Human, Single-Dose, Open-label, Positron Emission Tomography(PET) Imaging Study of [68Ga]MLN6907 in Patients with Metastatic Colorectal Carcinoma
    Daniel Berg
  5. An Open Label, Randomized (2:1) Phase IIb Study of Dasatinib Versus Imatinib in Patients With Chronic Phase Chronic Myeloid Leukemia Who Have Not Achieved an Optimal Response to 3 Months of Therapy Wi…
    Usha Perepu
  6. A Phase II Double-Blinded, Randomized, Placebo-Controlled Study of Docetaxel in Combination with 1-m(1)
    Alexandra Thomas
  7. A Phase III Randomized Trial Investigating Bortezomib (NSC# 681239) on a Modified Augmented BFM (ABF(1)
    Ayman El-Sheikh
  8. Interactionality of State-Trait Music Preference, Individual Variability, and Music Characteristics as a Multi-Axis Paradigm for Context-Specific Pain Perception and Management
    Xueli Tan
  9. Phase I/II Study of the Concomitant Administration of Indoximod Plus Ipilimumab for Adult Patients with Metastatic Melanoma
    Yousef Zakharia
  10. Modular Phase II Study to Link Targeted Therapy to Patients With Pathway Activated Tumors: Module 3 - MEK162 for Patients With RAS/RAF/MEK Activated Tumors
    Daniel Vaena
  11. A Randomised, Double-Blind, Parallel Group, Placebo-controlled Multi-Centre Phase III Study to Assess the Efficacy and Safety of Olaparib Versus Placebo as Adjuvant Treatment in Patients with Germline…
    Alexandra Thomas
  12. Longitudinal Assessment of Ovarian Reserve in Adolescents with Lymphoma
    Ayman El-Sheikh
  13. A Phase 3, Randomized, Placebo-controlled, Multicenter, Double-blind Study to Evaluate the Safety and Efficacy of Telotristat Etiprate (LX1606)...
    Joseph Dillon
  14. A Phase 1, First-in-Human, Single-Dose, Open-Label, Positron Emission Tomography (PET) Imaging Study of [68Ga]MLN6907 in Patients With...
    Daniel Berg
  15. A Phase II Double-Blinded, Randomized, Placebo-Controlled Study of Docetaxel in Combination with 1-methyl-D-tryptophan (indoximod) in Metastatic Breast Cancer
    Alexandra Thomas
  16. A Phase III Randomized Trial Investigating Bortezomib (NSC# 681239) on a Modified Augmented BFM (ABFM) Backbone in Newly Diagnosed T-Lymphoblastic Leukemia (T-ALL) and T- Lymphoblastic Lymphoma (T-LLy…
    Ayman El-Sheikh
  17. A Randomized, Double-Blind Placebo-Controlled Phase I Trial Evaluating the Safety and Pharmacokinetics of Oxfendazole
    Patricia Winokur
  18. A Phase II Randomized, Partially-Blinded, Controlled Trial in Healthy Adults Aged 65 Years and Older...
    Pat Winokur
  19. A Multi-center Phase II Trial Randomizing Novel Approaches for Graft-versus-Host Disease Prevention Compared to Contemporary Controls
    Margarida Magalhaes-Silverman
  20. Phase 3 Study Comparing Daratumumab, Lenalidomide, and Dexamethasone (DRd) vs Lenalidomide and Dexamethasone (Rd)...
    Guido Tricot

We welcome your feedback! Please help us improve your experience on our website by completing a brief survey.